Stay updated with breaking news from Lymphocyte Activation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Capital One Financial initiated coverage on shares of Immutep (NASDAQ:IMMP – Free Report) in a research note issued to investors on Friday, MarketBeat.com reports. The brokerage issued an overweight rating and a $10.00 target price on the biotechnology company’s stock. Immutep Stock Up 4.7 % Immutep stock opened at $3.10 on Friday. The firm’s 50-day […]
Capital One Financial began coverage on shares of Immutep (NASDAQ:IMMP – Free Report) in a research note released on Friday, Marketbeat reports. The brokerage issued an overweight rating and a $10.00 price target on the biotechnology company’s stock. Immutep Stock Performance NASDAQ IMMP opened at $3.10 on Friday. Immutep has a 1 year low of […]
Meridian Wealth Management LLC raised its holdings in Immutep Limited (NASDAQ:IMMP – Free Report) by 3.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 322,450 shares of the biotechnology company’s stock after purchasing an additional 11,250 shares during the quarter. Meridian Wealth […]
Media Release Excellent clinical data reported from TACTI-002 Phase II trial, including median Overall Survival of 35.5 months in first line non-small cell lung cancer patients expressing PD-L1...
Media ReleaseSYDNEY, AUSTRALIA, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ('Immutep” or “the Company”), a clini...